{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:40:19Z","timestamp":1792640419838,"version":"4.5.0"},"reference-count":60,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among reproductive-aged females, and women with PCOS are at increased risk for endometrial cancer (EndoCA), the most common gynecological malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Our study sought to assess the economic burden associated with EndoCA in PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Using PRISMA systematic review guidelines, we evaluated studies on EndoCA rates in patients with PCOS. Excluded studies were reviews and case reports, those with nonhuman subjects, without controls, without full text available, or reporting solely on other conditions. Selected studies were assessed for quality using the Newcastle-Ottawa Scale. Meta-analysis used DerSimonian-Laird random effects model to assess pooled risk ratio (RR). Excess cost was assessed in US dollars (USD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Of 98 studies screened, 9 were included. Pooled RR for EndoCA in PCOS was 3.46 (95% CI, 2.28-5.23), P \u2264 .001. In the United States, prevalence of EndoCA in patients with PCOS in 2020 was 1.712%, compared with a baseline estimated prevalence in all women of 0.489%. The excess prevalence of EndoCA attributable to PCOS was 1.223%, approximately 98 348 affected women. A population attributable fraction of EndoCA for PCOS was 24.4%. Given estimated costs of EndoCA exceeding $1.9 billion (in 2023 USD), the economic burden of EndoCA attributable to PCOS exceeds $467 million\/year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The excess annual US healthcare cost for EndoCA attributable to PCOS exceeds $467 million\/year (2023 USD). Although a concerning morbidity of PCOS, it is notable that the economic burden of EndoCA attributable to the disorder represents only a small fraction of its total healthcare burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae527","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T22:23:41Z","timestamp":1722378221000},"page":"e168-e176","source":"Crossref","is-referenced-by-count":17,"title":["Economic Burden of Endometrial Cancer Associated With Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-9662","authenticated-orcid":false,"given":"Lauren","family":"Pace","sequence":"first","affiliation":[{"name":"Department of Ob\/Gyn, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, AL 35233 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7128-280X","authenticated-orcid":false,"given":"Daniela","family":"Markovic","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, The David Geffen School of Medicine, UCLA , Los Angeles, CA 90024 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9148-0692","authenticated-orcid":false,"given":"Richard","family":"Buyalos","sequence":"additional","affiliation":[{"name":"Department of Ob\/Gyn, The David Geffen School of Medicine, UCLA , Los Angeles, CA 90024 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-4396","authenticated-orcid":false,"given":"Fernando","family":"Bril","sequence":"additional","affiliation":[{"name":"Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, AL 35233 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-0483","authenticated-orcid":false,"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Department of Ob\/Gyn, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, AL 35233 ,","place":["USA"]},{"name":"Department of Ob\/Gyn and Medicine, Heersink School of Medicine, University of Alabama at Birmingham , Birmingham, AL 35233 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"2024121723531706800_dgae527-B1","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"2024121723531706800_dgae527-B2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2024121723531706800_dgae527-B3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2024121723531706800_dgae527-B4","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2005-0628","article-title":"Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span","volume":"90","author":"Azziz","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024121723531706800_dgae527-B5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/cen.13828","article-title":"Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews","volume":"89","author":"Gilbert","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024121723531706800_dgae527-B6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coemr.2020.03.001","article-title":"What causes anovulation in polycystic ovary syndrome?","volume":"12","author":"Franks","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"issue":"5-6","key":"2024121723531706800_dgae527-B7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0039-128X(98)00035-X","article-title":"Etiology of anovulation in polycystic ovary syndrome","volume":"63","author":"Franks","year":"1998","journal-title":"Steroids"},{"issue":"2","key":"2024121723531706800_dgae527-B8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"2024121723531706800_dgae527-B9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1423-0127-21-2","article-title":"Endometrial progesterone resistance and PCOS","volume":"21","author":"Li","year":"2014","journal-title":"J Biomed Sci"},{"issue":"20","key":"2024121723531706800_dgae527-B10","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024121723531706800_dgae527-B11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecol Oncol"},{"key":"2024121723531706800_dgae527-B12","author":"USCS Data Visualizations"},{"key":"2024121723531706800_dgae527-B13","author":"American Cancer Society | Cancer Facts & Statistics"},{"key":"2024121723531706800_dgae527-B14","first-page":"1","volume-title":"StatPearls","author":"Mahdy","year":"2023"},{"issue":"4","key":"2024121723531706800_dgae527-B15","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.3802\/jgo.2020.31.e52","article-title":"Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the medical expenditure panel survey 2007\u20132014","volume":"31","author":"Yue","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"2024121723531706800_dgae527-B16"},{"key":"2024121723531706800_dgae527-B17","doi-asserted-by":"crossref","first-page":"1027945","DOI":"10.3389\/fendo.2022.1027945","article-title":"Global trends in polycystic ovary syndrome research: a 10-year bibliometric analysis","volume":"13","author":"Shi","year":"2023","journal-title":"Front Endocrinol"},{"issue":"1","key":"2024121723531706800_dgae527-B18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12905-022-02015-2","article-title":"Trend changes and factor analysis of endometrial hyperplasia in patients with polycystic ovarian syndrome based on the Korean national health insurance database","volume":"22","author":"Park","year":"2022","journal-title":"BMC Womens Health"},{"issue":"11","key":"2024121723531706800_dgae527-B19","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.18203\/2320-1770.ijrcog20175010","article-title":"Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence?","volume":"6","author":"Choudhary","year":"2017","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"issue":"4","key":"2024121723531706800_dgae527-B20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978\u20132013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2024121723531706800_dgae527-B21","author":"Gierisch"},{"issue":"3","key":"2024121723531706800_dgae527-B22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"2024121723531706800_dgae527-B23","article-title":"SEER.","author":"Cancer of the Endometrium\u2014Cancer Stat Facts"},{"key":"2024121723531706800_dgae527-B24","author":"Key Statistics for Endometrial Cancer"},{"issue":"4","key":"2024121723531706800_dgae527-B25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","article-title":"Cost-of-illness studies: concepts, scopes, and methods","volume":"20","author":"Jo","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"2024121723531706800_dgae527-B26","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"2024121723531706800_dgae527-B27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil"},{"issue":"1","key":"2024121723531706800_dgae527-B28","first-page":"124","article-title":"Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women","volume":"77","author":"Escobedo","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"12","key":"2024121723531706800_dgae527-B29","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s10552-010-9658-7","article-title":"Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study","volume":"21","author":"Fearnley","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"1","key":"2024121723531706800_dgae527-B30","first-page":"89","article-title":"A case-control study of uterine endometrial cancer of pre- and post-menopausal women","volume":"7","author":"Niwa","year":"2000","journal-title":"Oncol Rep"},{"issue":"4","key":"2024121723531706800_dgae527-B31","first-page":"399","article-title":"Women younger than 50 years with endometrial cancer","volume":"27","author":"Iatrakis","year":"2006","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"2024121723531706800_dgae527-B32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/humrep\/dei420","article-title":"The association between polycystic ovaries and endometrial cancer","volume":"21","author":"Pillay","year":"2006","journal-title":"Hum Reprod"},{"issue":"4","key":"2024121723531706800_dgae527-B33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/CEJ.0b013e328329d830","article-title":"Hormone-related factors and gynecological conditions in relation to endometrial cancer risk","volume":"18","author":"Zucchetto","year":"2009","journal-title":"Eur J Cancer Prev"},{"issue":"1","key":"2024121723531706800_dgae527-B34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.2910490108","article-title":"A population-based case-control study of endometrial cancer in Shanghai, China","volume":"49","author":"Shu","year":"1991","journal-title":"Int J Cancer"},{"issue":"5","key":"2024121723531706800_dgae527-B35","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jpag.2019.06.004","article-title":"Risk factors for endometrial cancer or hyperplasia in adolescents and women 25 years old or younger","volume":"32","author":"Rosen","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2024121723531706800_dgae527-B36"},{"issue":"12","key":"2024121723531706800_dgae527-B37","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024121723531706800_dgae527-B38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/13696998.2021.1996958","article-title":"Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population","volume":"24","author":"Shah","year":"2021","journal-title":"J Med Econ"},{"issue":"8","key":"2024121723531706800_dgae527-B39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2217\/fon-2021-0727","article-title":"Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patients","volume":"18","author":"Nwankwo","year":"2022","journal-title":"Future Oncol"},{"issue":"1","key":"2024121723531706800_dgae527-B40","first-page":"97","article-title":"Endometrial adenocarcinoma and the stein-leventhal syndrome","volume":"51","author":"Jafari","year":"1978","journal-title":"Obstet Gynecol"},{"issue":"9371","key":"2024121723531706800_dgae527-B41","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/S0140-6736(03)13409-5","article-title":"Polycystic ovary syndrome and endometrial carcinoma","volume":"361","author":"Hardiman","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"2024121723531706800_dgae527-B42","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/ijc.23716","article-title":"The role of body weight in the relationship between physical activity and endometrial cancer: results from a large cohort of US women","volume":"123","author":"Patel","year":"2008","journal-title":"Int J Cancer"},{"issue":"12","key":"2024121723531706800_dgae527-B43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11912-018-0747-1","article-title":"Prevention strategies in endometrial carcinoma","volume":"20","author":"MacKintosh","year":"2018","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"2024121723531706800_dgae527-B44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ajog.2011.05.042","article-title":"Understanding obesity and endometrial cancer risk: opportunities for prevention","volume":"205","author":"Schmandt","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"2024121723531706800_dgae527-B45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpobgyn.2020.05.003","article-title":"Progesterone and endometrial cancer","volume":"69","author":"Gompel","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"2024121723531706800_dgae527-B46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2020.06.008","article-title":"Contemporary hormonal contraception and risk of endometrial cancer in women younger than age 50: a retrospective cohort study of Danish women","volume":"102","author":"Iversen","year":"2020","journal-title":"Contraception"},{"issue":"2","key":"2024121723531706800_dgae527-B47","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1210\/jc.2007-2287","article-title":"Effects of continuous versus cyclical oral contraception: a randomized controlled trial","volume":"93","author":"Legro","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2024121723531706800_dgae527-B48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0010-7824(03)00078-7","article-title":"Economic analysis of contraceptives for women","volume":"68","author":"Chiou","year":"2003","journal-title":"Contraception"},{"issue":"22","key":"2024121723531706800_dgae527-B49","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1200\/JCO.19.01240","article-title":"Beyond obesity: the rising incidence and mortality rates of uterine corpus cancer","volume":"37","author":"Mullins","year":"2019","journal-title":"J Clin Oncol"},{"issue":"22","key":"2024121723531706800_dgae527-B50","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","volume":"37","author":"Clarke","year":"2019","journal-title":"J Clin Oncol"},{"key":"2024121723531706800_dgae527-B51","author":"Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women"},{"issue":"1","key":"2024121723531706800_dgae527-B52","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2023.04.010","article-title":"Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019","volume":"229","author":"Yu","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 5","key":"2024121723531706800_dgae527-B53","first-page":"1285","article-title":"Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield","year":"2000","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2024121723531706800_dgae527-B54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"issue":"4","key":"2024121723531706800_dgae527-B55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09513590.2017.1395842","article-title":"Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function","volume":"34","author":"Carmina","year":"2018","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2024121723531706800_dgae527-B56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.5114\/aoms.2019.87112","article-title":"National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: the modeled estimates from the global burden of disease study 2016","volume":"17","author":"Miazgowski","year":"2019","journal-title":"Arch Med Sci"},{"issue":"2","key":"2024121723531706800_dgae527-B57","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990\u20132019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2024121723531706800_dgae527-B58","doi-asserted-by":"crossref","first-page":"e221229","DOI":"10.1001\/jamahealthforum.2022.1229","article-title":"Comparison of cancer-related spending and mortality rates in the US vs 21 high-income countries","volume":"3","author":"Chow","year":"2022","journal-title":"JAMA Health Forum"},{"issue":"11","key":"2024121723531706800_dgae527-B59","doi-asserted-by":"crossref","first-page":"e0165539","DOI":"10.1371\/journal.pone.0165539","article-title":"Long-term secondary care costs of endometrial cancer: a prospective cohort study nested within the United Kingdom collaborative trial of ovarian cancer screening (UKCTOCS)","volume":"11","author":"Pennington","year":"2016","journal-title":"PLoS One"},{"key":"2024121723531706800_dgae527-B60"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae527\/58838644\/dgae527.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/1\/e168\/61213661\/dgae527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/1\/e168\/61213661\/dgae527.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T18:54:22Z","timestamp":1734461662000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/1\/e168\/7728038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,6]]},"published-print":{"date-parts":[[2024,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae527","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,8,6]]}}}